Inventor
LIU YUGANG
CN28 patents
⚠️ This page may combine multiple inventors who share the name “LIU YUGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZHOU MINGJIE
13 patentsUS8217370B2Jul 10, 2012
Luminescent glass element, producing method thereof and luminescing method thereof
ZHOU MINGJIE2 citations63
US8217369B2Jul 10, 2012
Luminescent glass element, producing method thereof and luminescing method thereof
ZHOU MINGJIE2 citations63
US8216671B2Jul 10, 2012
Luminescent glass element, producing method thereof and luminescing method thereof
ZHOU MINGJIE5 citations63
US8115181B2Feb 14, 2012
Luminescent glass element, producing method thereof and luminescing method thereof
ZHOU MINGJIE3 citations63
US9101035B2Aug 4, 2015
Luminescent element, its preparation method thereof and luminescene method
ZHOU MINGJIE0 citations52
US9087685B2Jul 21, 2015
Method for raising luminous efficiency of field emissive luminescent material, luminescent glass element and the preparing method thereof
ZHOU MINGJIE0 citations52
US8415017B2Apr 9, 2013
Luminescent glass element, producing method thereof and luminescing method thereof
ZHOU MINGJIE0 citations52
US9102874B2Aug 11, 2015
Luminescent element, preparation method thereof and luminescence method
ZHOU MINGJIE0 citations51
US9096799B2Aug 4, 2015
Luminescent element, preparation method thereof and luminescence method
ZHOU MINGJIE1 citations51
US9096796B2Aug 4, 2015
Luminescent element, preparation method thereof and luminescence method
ZHOU MINGJIE0 citations51
US9000667B2Apr 7, 2015
Luminescent element, preparation method thereof and luminescence method
ZHOU MINGJIE1 citations51
US8525400B2Sep 3, 2013
Luminescent element, preparation method thereof and luminescence method
ZHOU MINGJIE0 citations51
US8747681B2Jun 10, 2014
Preparation method of fluorescent powder layer
ZHOU MINGJIE0 citations42
NOVARTIS AG
5 patentsUS8008263B2Aug 30, 2011
Organic compounds and their uses
NOVARTIS AG12 citations82
US11932630B2Mar 19, 2024
Heteroaryl aminopropanol derivatives
NOVARTIS AG2 citations69
US11426375B2Aug 30, 2022
Substituted bisphenyl butanoic ester derivatives as NEP inhibitors
NOVARTIS AG0 citations56
US10668035B2Jun 2, 2020
Substituted bisphenyl butanoic ester derivatives as NEP inhibitors
NOVARTIS AG1 citations56
US7915264B2Mar 29, 2011
Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
NOVARTIS AG0 citations49
FENG LILI
2 patentsUS8877938B2Nov 4, 2014
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
FENG LILI44 citations95
US9388134B2Jul 12, 2016
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
FENG LILI5 citations81
DE LA CRUZ MARILYN
2 patentsNOVARTIS PHARMACEUTICALS CORP
2 patentsUS11642329B2May 9, 2023
Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations
NOVARTIS PHARMACEUTICALS CORP0 citations60
US11096918B2Aug 24, 2021
Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations
NOVARTIS PHARMACEUTICALS CORP0 citations60